74 results on '"Tay, Edgar"'
Search Results
2. Assessing the Impact of Transcatheter Aortic Valve Implantation on Cardiac Catheterisation: A Multicentric Study
3. An Asian Perspective on Gender Differences in Clinical Outcomes and Echocardiographic Profiles of Patients With Medically Managed Severe Aortic Stenosis
4. Differences in Clinical and Echocardiographic Profiles and Outcomes of Patients With Atrial Fibrillation Versus Sinus Rhythm in Medically Managed Severe Aortic Stenosis and Preserved Left Ventricular Ejection Fraction
5. Use of endothelial progenitor cell capture stent (Genous Bio-Engineered R Stent) during primary percutaneous coronary intervention in acute myocardial infarction: Intermediate- to long-term clinical follow-up
6. An unusual cause of heart failure
7. Mortality and hospitalization outcomes of interstitial lung disease and pulmonary hypertension in the Singapore systemic sclerosis cohort.
8. Clinical Outcomes Following Transcatheter Aortic Valve Replacement in Asian Population.
9. PREDICTORS OF MORTALITY FOR SEVERE ATRIAL FIBRILLATION-RELATED FUNCTIONAL TRICUSPID REGURGITATION.
10. A High-Risk Period for Cerebrovascular Events Exists After Transcatheter Aortic Valve Implantation.
11. Replacement therapy for iron deficiency improves exercise capacity and quality of life in patients with cyanotic congenital heart disease and/or the Eisenmenger syndrome
12. Quality of life and functional capacity can be improved in patients with Eisenmenger syndrome with oral sildenafil therapy
13. Exercise intolerance in patients with congenitally corrected transposition of the great arteries relates to right ventricular filling pressures
14. Outcome of Patients After Transcatheter Aortic Valve Embolization.
15. Multislice Computed Tomography for Prediction of Optimal Angiographic Deployment Projections During Transcatheter Aortic Valve Implantation.
16. An Embolic Deflection Device for Aortic Valve Interventions.
17. Transcatheter Aortic Valve Implantation in Patients With Bicuspid Aortic Valve Stenosis.
18. Transcatheter Closure of Paravalvular Defects Using a Purpose-Specific Occluder.
19. Echocardiographic quantification of pulmonary artery systolic pressure in ventricular septal defect: Do calculations from Doppler interrogation across tricuspid regurgitation and ventricular septal defect correlate?
20. SEVERE FUNCTIONAL TRICUSPID VALVE REGURGITATION: PREDICTORS OF MORTALITY AND HEART FAILURE ADMISSION.
21. Successful Transcatheter Aortic Valve Replacement for Severe Aortic Valve Regurgitation Following a David I Valve-Sparing Procedure.
22. Sustained benefit of tadalafil in patients with pulmonary arterial hypertension with prior response to sildenafil: A case series of 12 patients
23. Outcomes from MitraClip Therapy in Functional Compared to Degenerative Mitral Regurgitation: Multi-centre Experience from the MitraClip Asia-Pacific Registry (MARS).
24. COMPARISON OF PATIENTS WITH LOW–FLOW VERSUS NORMAL–FLOW SEVERE AORTIC STENOSIS WITH PRESERVED LEFT VENTRICULAR EJECTION FRACTION
25. THE PREVALENCE OF THE “LOW–FLOW” PHENOMENON IN PATIENTS WITH MILD, MODERATE AND SEVERE AORTIC STENOSIS
26. CRT-140 Percutaneous Mitral Valve Repair with MitraClip Restores Exercise Capacity in Patients with Symptomatic Severe Functional Mitral Regurgitation who are Not Surgical Candidates.
27. MORTALITY ON THE WAITING LIST FOR TRANSCATHETER AORTIC VALVE IMPLANTATION. A SINGLE CENTER EXPERIENCE FROM VANCOUVER, CANADA
28. LONG TERM DURABILITY OF EDWARDS BALLOON EXPANDABLE TRANSCATHETER AORTIC VALVE IMPLANTATION
29. Impact of Left Ventricular Ejection Fraction on Clinical Outcomes in Bicuspid Aortic Valve Disease.
30. ASSOCIATION OF LEFT VENTRICULAR DILATATION PATTERNS WITH MORTALITY IN PATIENTS WITH MODERATE AND MODERATE-SEVERE AORTIC REGURGITATION.
31. Long-Term Clinical Outcomes of Biodegradable-Polymer Drug-Eluting Stents Versus Second-Generation Durable-Polymer Drug-Eluting Stents for ST-Segment Elevation Myocardial Infarction.
32. Outcomes of left ventricular thrombosis in post-acute myocardial infarction patients stratified by antithrombotic strategies: A meta-analysis with meta-regression.
33. The neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predict left ventricular thrombus resolution in acute myocardial infarction without percutaneous coronary intervention.
34. Treating Very Long Coronary Artery Lesions in the Contemporary Drug-Eluting-Stent Era: Single Long 48 mm Stent Versus Two Overlapping Stents Showed Comparable Clinical Outcomes.
35. Clinical Outcomes One Year and Beyond After Combination Sirolimus-Eluting Endothelial Progenitor Cell Capture Stenting During Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction.
36. Post-operative ventricular flow dynamics following atrioventricular valve surgical and device therapies: A review.
37. IMPACT OF DIFFERING STAGES OF CHRONIC KIDNEY DISEASE ON TRANSCATHETER AORTIC VALVE IMPLANTATION OUTCOME IN AN ASIAN POPULATION.
38. SAFETY AND EFFICACY OF THE COMBINATION SIROLIMUS-ELUTING ENDOTHELIAL PROGENITOR CELL CAPTURE STENT IN PATIENTS WITH ST-SEGMENT ELEVATION ACUTE MYOCARDIAL INFARCTION: ONE YEAR FOLLOW-UP.
39. Transcatheter Aortic Valve Replacement With Early- and New-Generation Devices in Bicuspid Aortic Valve Stenosis.
40. Atrial tachyarrhythmias late after Fontan operation are related to increase in mortality and hospitalization
41. Effectiveness and Safety of the Genous Endothelial Progenitor Cell-Capture Stent in Acute ST-Elevation Myocardial Infarction
42. Usefulness of Natriuretic Peptide Levels to Predict Mortality in Adults With Congenital Heart Disease
43. SEVERE ATRIAL FIBRILLATION-RELATED FUNCTIONAL TRICUSPID VALVE REGURGITATION: PREDICTORS FOR HEART FAILURE ADMISSIONS.
44. THE ETHNIC GAP IN CLINICAL OUTCOMES OF SIGNIFICANT AORTIC STENOSIS IN THE ASIAN POPULATION.
45. THE ASIAN PERSPECTIVE OF DIMENSIONLESS INDEX IN PATIENTS WITH LOW-GRADIENT SEVERE AORTIC STENOSIS WITH PRESERVED EJECTION FRACTION.
46. Impact of different Asian ethnic groups on correlation between heparin dose, activated clotting time and complications in percutaneous coronary intervention
47. ETHNIC DIFFERENCES IN COMPUTED TOMOGRAPHY AORTIC VALVE CALCIUM QUANTIFICATION IN PATIENTS WITH AORTIC STENOSIS.
48. INADEQUATELY LOW LEFT VENTRICULAR MASS IN PATIENTS WITH AORTIC VALVE STENOSIS: IMPROVED LEFT VENTRICULAR CONTRACTILITY AND CLINICAL OUTCOMES?
49. TCT-638 Diabetes Mellitus Confers Worse Clinical Outcomes at 1 Year Compared to Non–Diabetes Mellitus in an All-Comer Population Implanted With Biodegradable Polymer Everolimus-Eluting Stents.
50. TCT-305 Real-World Experience of Biodegradable-Polymer Drug Eluting Stents Versus Second-Generation Durable-Polymer Drug-Eluting Stents in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.